| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-04 02:34:41 UTC |
|---|
| Updated at | 2022-09-04 02:34:41 UTC |
|---|
| NP-MRD ID | NP0186647 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | methyl (1s,14s,15r,18s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate |
|---|
| Description | Dregamine belongs to the class of organic compounds known as vobasan alkaloids. These are alkaloids containing the vobasan skeleton. Dregamine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. methyl (1s,14s,15r,18s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate is found in Tabernaemontana calcarea. methyl (1s,14s,15r,18s)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate was first documented in 2019 (PMID: 30987224). Based on a literature review a small amount of articles have been published on dregamine (PMID: 33189435) (PMID: 30048730) (PMID: 34577562) (PMID: 33899955). |
|---|
| Structure | CC[C@H]1CN(C)[C@H]2CC3=C(NC4=CC=CC=C34)C(=O)C[C@@H]1[C@@H]2C(=O)OC InChI=1S/C21H26N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h5-8,12,14,17,19,22H,4,9-11H2,1-3H3/t12-,14-,17-,19-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (-)-Dregamine | ChEBI | | 20-Epitabernemontanine | ChEBI |
|
|---|
| Chemical Formula | C21H26N2O3 |
|---|
| Average Mass | 354.4500 Da |
|---|
| Monoisotopic Mass | 354.19434 Da |
|---|
| IUPAC Name | methyl (1S,14S,15R,18S)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8-tetraene-18-carboxylate |
|---|
| Traditional Name | methyl (1S,14S,15R,18S)-15-ethyl-17-methyl-12-oxo-10,17-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8-tetraene-18-carboxylate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@H]1CN(C)[C@H]2CC3=C(NC4=CC=CC=C34)C(=O)C[C@@H]1[C@@H]2C(=O)OC |
|---|
| InChI Identifier | InChI=1S/C21H26N2O3/c1-4-12-11-23(2)17-9-15-13-7-5-6-8-16(13)22-20(15)18(24)10-14(12)19(17)21(25)26-3/h5-8,12,14,17,19,22H,4,9-11H2,1-3H3/t12-,14-,17-,19-/m0/s1 |
|---|
| InChI Key | FFVRRQMGGGTQRH-YWKPPDPDSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as vobasan alkaloids. These are alkaloids containing the vobasan skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Vobasan alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Vobasan alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Vobasan skeleton
- 3-alkylindole
- Indole
- Indole or derivatives
- Piperidinecarboxylic acid
- Aryl ketone
- Aryl alkyl ketone
- Aralkylamine
- Benzenoid
- Piperidine
- Heteroaromatic compound
- Methyl ester
- Pyrrole
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Ketone
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Amine
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Organic oxide
- Carbonyl group
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Zhou J, Du SY, Dong HJ, Fang L, Feng JH: Preparative Separation of Monoterpenoid Indole Alkaloid Epimers from Ervatamia yunnanensis Tsiang by pH-Zone-Refining Counter-Current Chromatography Combined with Preparative High-Performance Liquid Chromatography. Molecules. 2019 Apr 3;24(7). pii: molecules24071316. doi: 10.3390/molecules24071316. [PubMed:30987224 ]
- Cardoso DSP, Kincses A, Nove M, Spengler G, Mulhovo S, Aires-de-Sousa J, Dos Santos DJVA, Ferreira MU: Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells. Eur J Med Chem. 2021 Jan 15;210:112985. doi: 10.1016/j.ejmech.2020.112985. Epub 2020 Nov 4. [PubMed:33189435 ]
- Bapela MJ, Heyman H, Senejoux F, Meyer JJM: (1)H NMR-based metabolomics of antimalarial plant species traditionally used by Vha-Venda people in Limpopo Province, South Africa and isolation of antiplasmodial compounds. J Ethnopharmacol. 2019 Jan 10;228:148-155. doi: 10.1016/j.jep.2018.07.022. Epub 2018 Jul 23. [PubMed:30048730 ]
- Cardoso DSP, Szemeredi N, Spengler G, Mulhovo S, Dos Santos DJVA, Ferreira MU: Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer. Pharmaceuticals (Basel). 2021 Aug 28;14(9):862. doi: 10.3390/ph14090862. [PubMed:34577562 ]
- Raimundo L, Paterna A, Calheiros J, Ribeiro J, Cardoso DSP, Piga I, Neto SJ, Hegan D, Glazer PM, Indraccolo S, Mulhovo S, Costa JL, Ferreira MU, Saraiva L: BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer. Br J Pharmacol. 2021 Sep;178(18):3627-3647. doi: 10.1111/bph.15506. Epub 2021 Jun 11. [PubMed:33899955 ]
- LOTUS database [Link]
|
|---|